These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 15767184

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
    Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA.
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Results of a study on fatigue in breast cancer patients receiving adjuvant chemotherapy: the first four days after treatment are the worst].
    de Jong N, Kester AD, Schouten HC, Abu-Saad HH, Courtens AM.
    Pflege Z; 2007 Nov; 60(11):620-5. PubMed ID: 18062627
    [Abstract] [Full Text] [Related]

  • 26. The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer.
    Fan HG, Park A, Xu W, Yi QL, Braganza S, Chang J, Couture F, Tannock IF.
    Psychooncology; 2009 Feb; 18(2):156-61. PubMed ID: 18561284
    [Abstract] [Full Text] [Related]

  • 27. The impact of age on Health-Related Quality of Life (HRQoL) and symptoms among postmenopausal women with breast cancer receiving adjuvant chemotherapy.
    Browall MM, Ahlberg KM, Persson LO, Karlsson PO, Danielson EB.
    Acta Oncol; 2008 Feb; 47(2):207-15. PubMed ID: 18210297
    [Abstract] [Full Text] [Related]

  • 28. Does cognitive impairment after chemotherapy for breast cancer improve over time or does practice make perfect?
    Schagen SB, van Dam FS.
    J Clin Oncol; 2006 Nov 10; 24(32):5170-1; author reply 5171-2. PubMed ID: 17093282
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
    Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S.
    Psychooncology; 2009 Aug 10; 18(8):811-21. PubMed ID: 19085975
    [Abstract] [Full Text] [Related]

  • 31. One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer.
    Noal S, Levy C, Hardouin A, Rieux C, Heutte N, Ségura C, Collet F, Allouache D, Switsers O, Delcambre C, Delozier T, Henry-Amar M, Joly F.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):795-803. PubMed ID: 20888704
    [Abstract] [Full Text] [Related]

  • 32. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
    Bernhard J, Zahrieh D, Castiglione-Gertsch M, Hürny C, Gelber RD, Forbes JF, Murray E, Collins J, Aebi S, Thürlimann B, Price KN, Goldhirsch A, Coates AS, International Breast Cancer Study Group Trial VIII.
    J Clin Oncol; 2007 Jan 20; 25(3):263-70. PubMed ID: 17159194
    [Abstract] [Full Text] [Related]

  • 33. Cognitive impairment associated with adjuvant therapy in breast cancer.
    Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, Ryan CM.
    Psychooncology; 2006 May 20; 15(5):422-30. PubMed ID: 16097037
    [Abstract] [Full Text] [Related]

  • 34. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE, Dodd MJ, Miaskowski CA, Dowling GA, Kramer J.
    Psychooncology; 2008 Dec 20; 17(12):1189-95. PubMed ID: 18506671
    [Abstract] [Full Text] [Related]

  • 35. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
    Wefel JS, Saleeba AK, Buzdar AU, Meyers CA.
    Cancer; 2010 Jul 15; 116(14):3348-56. PubMed ID: 20564075
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: a pilot study.
    Payne J, Piper B, Rabinowitz I, Zimmerman B.
    Oncol Nurs Forum; 2006 Jul 01; 33(4):775-83. PubMed ID: 16858459
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Survivorship and complications of treatment in breast cancer.
    Mrozek E, Shapiro CL.
    Clin Adv Hematol Oncol; 2005 Mar 01; 3(3):211-22, 238. PubMed ID: 16166992
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.